BEDFORD, Mass. -- Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in asset optimization software announced today that it has acquired Camo Analytics AS, a leading provider of industrial analytics based in Norway. The technology and expertise acquired with Camo Analytics will further strengthen AspenTech’s solutions to drive higher levels of performance, profitability and consistent quality for industries [...]

SaudiVax intends to increase access to vaccines to 20 times more people in the Middle East and Africa than today First bioprocessing facility for halal vaccines in-region, for region Remote Factory Acceptance Testing (FAT) helped avoid COVID-19 related delays   Cytiva, a global life sciences leader, is installing its first FlexFactory in the Middle East [...]

LexaGene Receives Purchase Order from a Multinational Biotechnology Company BEVERLY, Mass. USA – LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it has received a purchase order for a MiQLab™ system from a multinational biotechnology company that generates billions [...]

High-throughput screening for applications in virology, immunotherapy, oncology, receptor-signaling, and more Axion BioSystems has launched the Maestro ZHT high-throughput screening platform, leveraging their expertise in live-cell instrumentation to add a new dimension to drug discovery and development. Rapid technological advances are leading to a host of new drug, biologic, and cell-based therapeutics, creating new medical treatments thought [...]

Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials Cytiva provides FlexFactoryTM bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development [...]

-- Panel Distinguishes Between More than 3,000 Different infectious Diseases -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of the Twist Comprehensive Viral Research Panel, a next-generation sequencing (NGS) panel that includes more [...]

- Partners with Ginkgo Bioworks on “Ginkgo Challenge” -- SAN FRANCISCO & CAMBRIDGE, Mass. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced its continued partnership with the International Genetically Engineered Machine (iGEM) Foundation. As a long-time supporter of iGEM, in [...]

LC 300™ platform and SimplicityChrom™ software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance WALTHAM, Mass. --  PerkinElmer, Inc., today introduced the LC 300™ platform and SimplicityChrom™ software, bringing together advanced high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) capabilities with intuitive instrument control and data analysis. The new solution [...]

IDT is iGEM Platinum Sponsor for 7th year, providing products, educational content, and mentoring to international participants CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, is continuing its long-time support of the International Genetically Engineered Machine (iGEM) Foundation as a platinum sponsor for the upcoming iGEM 2020 competition. The event [...]

FUJIFILM Cellular Dynamics grants Lonza a non-exclusive right to use their patents related to iPSC generation, including episomal vectors and reprogramming factors, for development and clinical manufacture of iPSC lines for cell therapies  Lonza grants FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative NucleofectorTM technology The agreement enables drug developers to [...]